Table II.
Crystallization Leads
| Sample | Detergent | MSC | HR INDEX | MemGold | Total |
|---|---|---|---|---|---|
| MP01 | FC-12 + C12M | 1 | 0 | 0 | 1 |
| MP02 | FC-12 + C12E8 | 0 | 0 | 1 | 1 |
| MP03 | C10M | 0 | 0 | 0 | 0 |
| MP04 | C12E8 + C12M | 9 | 0 | 0 | 9 |
| MP05 | β-OG | 138 | 3 | 3 | 144 |
| MP06 | CYMAL-3 | 44 | 2 | 0 | 46 |
| MP07 | CYMAL-3 | 6 | 0 | 0 | 6 |
| MP08 | LDAO | 63 | 5 | 1 | 69 |
| MP09 | LDAO | 19 | 0 | 3 | 22 |
| MP10 | FC-12 + C12M | 6 | 0 | 1 | 7 |
| MP11 | C12M | 1 | 1 | 0 | 2 |
| MP12 | C12M | 76 | 0 | 15 | 91 |
| COX-2 | β-OG | 13 | 1 | 3 | 17 |
| GlpT | C12M | 1 | 0 | 1 | 2 |
The number of crystallization leads identified for the 12 membrane proteins of unknown structure and positive controls (COX-2 and GlpT) broken down by cocktails derived from the phase boundary data (MSC), the Hampton Research Index Screen (HR INDEX), and the Molecular Dimensions MemGold Screen (MemGold). The crystallization detergent(s) for each sample is also listed.